HWPC(SH:688799) Xin Lang Cai Jing·2025-09-18 03:26Core Insights - Warner Pharmaceutical's stock increased by 5.11% to 60.88 CNY per share, with a trading volume of 207 million CNY and a turnover rate of 2.68%, resulting in a total market capitalization of 7.995 billion CNY [1] Company Overview - Hunan Warner Pharmaceutical Co., Ltd. is located in Changsha, Hunan Province, and was established on April 30, 2001, with its listing date on July 13, 2021 [1] - The company's main business includes the research, production, and sales of chemical raw materials, chemical drug formulations, and traditional Chinese medicine formulations [1] - Revenue composition: Formulations account for 73.19%, raw materials and intermediates 25.22%, technical services 1.52%, plant extracts and food 0.06%, and others 0.01% [1] Shareholder Insights - Anxin Fund's Anxin Medical Health Stock A (010709) is among the top ten circulating shareholders of Warner Pharmaceutical, having increased its holdings by 504,400 shares in Q2, totaling 1,229,400 shares, which represents 0.94% of the circulating shares [2] - The estimated floating profit from this investment is approximately 3.639 million CNY [2] Fund Performance - Anxin Medical Health Stock A (010709) has a total asset size of 444 million CNY and has achieved a year-to-date return of 78.02%, ranking 57 out of 4,222 in its category [2] - Over the past year, the fund has returned 98.91%, ranking 578 out of 3,804, and since inception, it has achieved a return of 69.99% [2] Fund Manager Insights - The fund manager of Anxin Medical Health Stock A is Chi Chenshen, who has been in the position for 4 years and 251 days, with a total asset size of 946 million CNY [3] - The best fund return during his tenure is 72.35%, while the worst return is 68.37% [3] Fund Holdings - Anxin Medical Health Stock A (010709) has Warner Pharmaceutical as its sixth-largest holding, with 1,229,400 shares, accounting for 5.37% of the fund's net value [4] - The estimated floating profit from this position is also approximately 3.639 million CNY [4]